HER2-POSITIVE SOLID TUMOR
Clinical trials for HER2-POSITIVE SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE SOLID TUMOR trials appear
Sign up with your email to follow new studies for HER2-POSITIVE SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HER2 cancers: first human trial launches
Disease control Recruiting nowThis early-phase trial tests an experimental drug called YH32367 in people with HER2-positive solid tumors that have spread or cannot be removed by surgery. The study has two parts: first, finding a safe dose, then testing that dose in specific cancer types like biliary tract can…
Matched conditions: HER2-POSITIVE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New imaging trick could sharpen cancer scans
Diagnosis Recruiting nowThis early-phase study tests a new imaging agent (TGW211) in 19 adults with HER2-positive solid tumors. The goal is to see if a special 'trigger' can help clear the imaging tracer from healthy tissues faster, making tumor scans clearer. The study focuses on safety and image quali…
Matched conditions: HER2-POSITIVE SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC